415 related articles for article (PubMed ID: 21194375)
21. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
[TBL] [Abstract][Full Text] [Related]
22. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
23. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
Christen MT; Frank P; Schaller J; Llinás M
Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
[TBL] [Abstract][Full Text] [Related]
24. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
25. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
[TBL] [Abstract][Full Text] [Related]
26. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
27. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
Xue S; Madison EL; Miles LA
Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
[TBL] [Abstract][Full Text] [Related]
28. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
Kim HK; Joe YA
Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
[TBL] [Abstract][Full Text] [Related]
29. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
30. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
Taran LD; Makogonenko EM
Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of a recombinant anti-angiogenic kringle fragment expressed in Escherichia coli: Purification and characterization of a tri-kringle fragment from human apolipoprotein (a) (kringle IV (9)-kringle IV (10)-kringle V).
Kang KY; Kim SG; Kim WK; You HK; Kim YJ; Lee JH; Jung KH; Kim CW
Protein Expr Purif; 2006 Jan; 45(1):216-25. PubMed ID: 16260151
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
[TBL] [Abstract][Full Text] [Related]
34. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
35. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
Silva MM; Thelwell C; Williams SC; Longstaff C
J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
[TBL] [Abstract][Full Text] [Related]
36. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
[TBL] [Abstract][Full Text] [Related]
37. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
Hancock MA; Spencer CA; Koschinsky ML
Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
[TBL] [Abstract][Full Text] [Related]
38. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
39. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
[TBL] [Abstract][Full Text] [Related]
40. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
